Login / Signup

Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type.

Cosimo Di RaimondoFarah R AbdullaJasmine ZainChristiane QuerfeldSteven T Rosen
Published in: British journal of haematology (2019)
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • multiple myeloma
  • advanced non small cell lung cancer
  • newly diagnosed
  • stem cell transplantation